Deconstructing the Neurobiology of Cannabis Use Disorder

Overview

Journal Nat Neurosci

Date 2020 Apr 7

PMID 32251385

Citations 31

Authors

Jacqueline-Marie N Ferland

Yasmin L Hurd

Affiliations

Soon will be listed here.

Abstract

There have been dramatic changes worldwide in the attitudes toward and consumption of recreational and medical cannabis. Cannabinoid receptors, which mediate the actions of cannabis, are abundantly expressed in brain regions known to mediate neural processes underlying reward, cognition, emotional regulation and stress responsivity relevant to addiction vulnerability. Despite debates regarding potential pathological consequences of cannabis use, cannabis use disorder is a clinical diagnosis with high prevalence in the general population and that often has its genesis in adolescence and in vulnerable individuals associated with psychiatric comorbidity, genetic and environmental factors. Integrated information from human and animal studies is beginning to expand insights regarding neurobiological systems associated with cannabis use disorder, which often share common neural characteristics with other substance use disorders, that could inform prevention and treatment strategies.

Citing Articles

Neural basis of adolescent THC-induced potentiation of opioid responses later in life.

Hubbard E, Derdeyn P, Galinato V, Wu A, Bartas K, Mahler S Neuropsychopharmacology. 2024; .

PMID: 39658631 DOI: 10.1038/s41386-024-02033-8.

A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.

Weng Y, Kruschwitz J, Rueda-Delgado L, Ruddy K, Boyle R, Franzen L Elife. 2024; 13.

PMID: 39235858 PMC: 11377036. DOI: 10.7554/eLife.97150.

[Cannabis use and cannabis use disorders].

Hoch E, Preuss U Nervenarzt. 2024; 95(9):781-796.

PMID: 39134752 DOI: 10.1007/s00115-024-01722-5.

Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing.

Castelblanco C, Springer S, Schantell M, John J, Coutant A, Horne L J Psychopharmacol. 2024; 38(8):724-734.

PMID: 39087306 PMC: 11471968. DOI: 10.1177/02698811241265764.

Association between cannabis use disorder and greater apathy in adults with HIV.

Britton M, DeFelice J, Porges E, Cohen R, Li Y, Wang Y Drug Alcohol Depend. 2024; 261:111354.

PMID: 38870567 PMC: 11549954. DOI: 10.1016/j.drugalcdep.2024.111354.

References

Ridenour T, Tarter R, Reynolds M, Mezzich A, Kirisci L, Vanyukov M . Neurobehavior disinhibition, parental substance use disorder, neighborhood quality and development of cannabis use disorder in boys. Drug Alcohol Depend. 2009; 102(1-3):71-7. PMC: 2759175. DOI: 10.1016/j.drugalcdep.2009.01.009. View

Katona I . Cannabis and Endocannabinoid Signaling in Epilepsy. Handb Exp Pharmacol. 2015; 231:285-316. DOI: 10.1007/978-3-319-20825-1_10. View

Cousijn J, Wiers R, Ridderinkhof K, van den Brink W, Veltman D, Goudriaan A . Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 2011; 59(4):3845-51. DOI: 10.1016/j.neuroimage.2011.09.046. View

Rogosch F, Oshri A, Cicchetti D . From child maltreatment to adolescent cannabis abuse and dependence: a developmental cascade model. Dev Psychopathol. 2010; 22(4):883-97. PMC: 3030981. DOI: 10.1017/S0954579410000520. View

Hines L, Morley K, Rijsdijk F, Strang J, Agrawal A, Nelson E . Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design. Psychol Med. 2018; 48(16):2786-2793. DOI: 10.1017/S0033291718000478. View

Haberstick B, Young S, Zeiger J, Lessem J, Hewitt J, Hopfer C . Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health. Drug Alcohol Depend. 2014; 136:158-61. PMC: 3963405. DOI: 10.1016/j.drugalcdep.2013.11.022. View

Hurd Y, Michaelides M, Miller M, Jutras-Aswad D . Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacology. 2013; 76 Pt B:416-24. PMC: 3858398. DOI: 10.1016/j.neuropharm.2013.07.028. View

Busquets-Garcia A, Bains J, Marsicano G . CB Receptor Signaling in the Brain: Extracting Specificity from Ubiquity. Neuropsychopharmacology. 2017; 43(1):4-20. PMC: 5719111. DOI: 10.1038/npp.2017.206. View

Schacht J, Hutchison K, Filbey F . Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology. 2012; 37(11):2368-76. PMC: 3442352. DOI: 10.1038/npp.2012.92. View

10.

Agrawal A, Chou Y, Carey C, Baranger D, Zhang B, Sherva R . Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry. 2017; 23(5):1293-1302. PMC: 5938138. DOI: 10.1038/mp.2017.200. View

11.

Mechoulam R, Parker L . The endocannabinoid system and the brain. Annu Rev Psychol. 2012; 64:21-47. DOI: 10.1146/annurev-psych-113011-143739. View

12.

Blanco C, Florez-Salamanca L, Secades-Villa R, Wang S, Hasin D . Predictors of initiation of nicotine, alcohol, cannabis, and cocaine use: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Am J Addict. 2018; 27(6):477-484. DOI: 10.1111/ajad.12764. View

13.

Chang L, Yakupov R, Cloak C, Ernst T . Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain. 2006; 129(Pt 5):1096-112. DOI: 10.1093/brain/awl064. View

14.

Bergamaschi M, Queiroz R, Chagas M, de Oliveira D, De Martinis B, Kapczinski F . Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011; 36(6):1219-26. PMC: 3079847. DOI: 10.1038/npp.2011.6. View

15.

Hanus L, Meyer S, Munoz E, Taglialatela-Scafati O, Appendino G . Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016; 33(12):1357-1392. DOI: 10.1039/c6np00074f. View

16.

OShea M, Singh M, McGregor I, Mallet P . Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol. 2004; 18(4):502-8. DOI: 10.1177/026988110401800407. View

17.

Wang H, Zhang M . The role of Ca²⁺-stimulated adenylyl cyclases in bidirectional synaptic plasticity and brain function. Rev Neurosci. 2012; 23(1):67-78. DOI: 10.1515/revneuro-2011-0063. View

18.

Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M . The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 2006; 26(11):2991-3001. PMC: 6673964. DOI: 10.1523/JNEUROSCI.4872-05.2006. View

19.

Fan N, Yang H, Zhang J, Chen C . Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. J Neurochem. 2009; 112(3):691-702. PMC: 2809144. DOI: 10.1111/j.1471-4159.2009.06489.x. View

20.

Hajos M, Hoffmann W, Kocsis B . Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry. 2008; 63(11):1075-83. DOI: 10.1016/j.biopsych.2007.12.005. View